Analysts Set Privia Health Group, Inc. (NASDAQ:PRVA) Price Target at $27.38

Privia Health Group, Inc. (NASDAQ:PRVA) has earned an average recommendation of “Buy” from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, eleven have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $27.38.

Several analysts have recently commented on PRVA shares. Barclays raised their price target on Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Thursday, April 10th. Truist Financial increased their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Canaccord Genuity Group increased their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Piper Sandler increased their price objective on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Finally, JMP Securities restated a “market outperform” rating and set a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 3,445 shares of Privia Health Group stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $80,371.85. Following the completion of the sale, the chief financial officer now directly owns 176,231 shares in the company, valued at $4,111,469.23. The trade was a 1.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Parth Mehrotra sold 13,773 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $24.99, for a total transaction of $344,187.27. Following the completion of the transaction, the chief executive officer now directly owns 423,143 shares of the company’s stock, valued at approximately $10,574,343.57. This represents a 3.15% decrease in their position. The disclosure for this sale can be found here. Insiders sold 51,579 shares of company stock valued at $1,226,367 in the last 90 days. 10.70% of the stock is currently owned by insiders.

Institutional Trading of Privia Health Group

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Barclays PLC boosted its holdings in shares of Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after purchasing an additional 158,188 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Privia Health Group by 8.4% during the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after buying an additional 14,641 shares during the period. Park Avenue Securities LLC boosted its stake in Privia Health Group by 3.8% in the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after buying an additional 532 shares during the last quarter. Financial Management Professionals Inc. purchased a new stake in Privia Health Group in the 4th quarter valued at about $51,000. Finally, Nisa Investment Advisors LLC increased its stake in shares of Privia Health Group by 185.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock valued at $98,000 after acquiring an additional 3,249 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Trading Up 2.5%

Shares of PRVA opened at $24.90 on Tuesday. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.09. The stock’s 50 day moving average is $23.34 and its two-hundred day moving average is $22.47. The firm has a market capitalization of $3.04 billion, a PE ratio of 249.02, a P/E/G ratio of 3.47 and a beta of 0.87.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.